Mississippi Code
Miss. Code Ann. § 83-9-8 (2024)
Coverage of drugs not approved by Federal Food and Drug Administration; drugs used in treatment of cancer
✓ Justia copy: laws through about 2024 (2025 and 2026 sessions missing)
- (1) No insurance policy which provides coverage for drugs shall exclude coverage of any such drug used for the treatment of cancer on the grounds that the drug has not been approved by the Federal Food and Drug Administration for the treatment of the specific type of cancer for which the drug has been prescribed, provided that such drug is recognized for treatment of that specific type of cancer in one of the standard reference compendia or in the medical literature.
- (2) This section may not be construed to:
- (a) Alter existing law with regard to provisions limiting the coverage of drugs that have not been approved by the Federal Food and Drug Administration;
- (b) Require coverage for any drug when the Federal Food and Drug Administration has determined its use to be contraindicated;
- (c) Require coverage for experimental drugs not otherwise approved for any indication by the Federal Food and Drug Administration;
- (d) Create, impair, alter, limit, modify, enlarge, abrogate or prohibit reimbursement for drugs used in the treatment of any other disease or condition.
- (3) For purposes of this section:
- (a) "Insurance policy" means an individual, group or blanket policy written by a medical expense indemnity corporation, a hospital service corporation, a health care service plan contract, or a private insurance plan issued, amended, delivered or renewed in this state or which provides insurance for residents of this state. This term shall include all health insurance plans for the state and its political subdivisions.
- (b) "Standard reference compendia" means:
- (i) The United States Pharmacopoeia Drug Information;
- (ii) The American Hospital Formulary Service Drug Information.
- (c) "Medical literature" means two (2) articles from major peer-reviewed professional medical journals that have recognized, based on scientific or medical criteria, the drug's safety and effectiveness for treatment of the indication for which it has been prescribed unless two (2) articles from major peer-reviewed professional medical journals have concluded, based on scientific or medical criteria, that the drug is unsafe or ineffective or that the drug safety and effectiveness cannot be determined for the treatment of the indication for which it has been prescribed. Peer-reviewed medical literature shall not include publications or supplements that are sponsored to a significant extent by a pharmaceutical manufacturing company or health carrier.
Laws, 1997, ch. 445, § 1, eff. 7/1/1997.
Notes of Decisions
Cited in 2
cases, 2011–2013 · leading case: Mississippi State & Sch. Employees' Life & Health Plan v. KCC, Inc., 108 So. 3d 932 (Miss. 2013).
Mississippi State & Sch. Employees' Life & Health Plan v. KCC, Inc., 108 So. 3d 932 (Miss. 2013). “Miss. Code Ann. § 83-9-8 (3). Subsections (6)-(9) provide: (6) A violation of this section creates a civil cause of action for injunctive relief in favor of any person or pharmacy aggrieved by the violation.”
Mississippi State v. KCC, Inc., No. 2011-CA-01716-SCT (Miss. Oct. 26, 2011). “” Miss. Code Ann. § 83-9-8 (3)(a). Because Section 83-9-8 deals with the scope and coverage of an insurance policy, a matter committed to the Board, the Legislature specifically announced that the section applies to the Plan.”
Miss. Code Ann. § 83-9-8(1): 1 case
Mississippi State & Sch. Employees' Life & Health Plan v. KCC, Inc., 108 So. 3d 932 (Miss. 2013). “Miss. Code Ann. § 83-9-8 (3). Subsections (6)-(9) provide: (6) A violation of this section creates a civil cause of action for injunctive relief in favor of any person or pharmacy aggrieved by the violation.”
Miss. Code Ann. § 83-9-8(3)(a): 1 case
Mississippi State & Sch. Employees' Life & Health Plan v. KCC, Inc., 108 So. 3d 932 (Miss. 2013). “Miss. Code Ann. § 83-9-8 (3). Subsections (6)-(9) provide: (6) A violation of this section creates a civil cause of action for injunctive relief in favor of any person or pharmacy aggrieved by the violation.”
Annotations are extracted automatically from the opinions in the
Syfert caselaw corpus and ranked by authority, recency, and
treatment. Dots show Syfertize treatment of the citing case itself.